CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers
Author:
Funder
Gilead Sciences
Publisher
Elsevier BV
Subject
Virology,Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Epidemiology
Reference48 articles.
1. Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs-First real world data from Austria;Schmidbauer;PLoS One,2020
2. Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapy;Schmidbauer;PLoS One,2021
3. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study;Lancet Gastroenterol Hepatol,2022
4. Hepatitis C elimination - macro-elimination;Kåberg;Liver Int Off J Int Assoc Study Liver,2020
5. A testing campaign intervention consisting of peer-facilitated engagement, point-of-care HCV RNA testing, and linkage to nursing support to enhance hepatitis C treatment uptake among people who inject drugs: the ETHOS engage study;Conway;Viruses,2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3